Though the exact mechanism through which Par3 affects tumor formation remains to be investigated, our observations may explain how Par3 may be involved in tumor malignancy, which could be largely dependent on the reconstitution of STAT3 signaling in ovarian cancer. Here, PARD3 is linked to ovarian carcinoma.